In DUBLIN-3 non-squamous EGFR WT NSCLC patients who progressed after anti-PD-(L)1, Plinabulin + docetaxel showed consistent and clinically ...

In DUBLIN-3 non-squamous EGFR WT NSCLC patients who progressed after anti-PD-(L)1, Plinabulin + docetaxel showed consistent and clinically meaningful improvements in OS, PFS, and ORR, reinforcing ...

A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an improved method for predicting ...

Discover why RGA Investment Advisors added Capital One (COF) to portfolios after its Discover acquisition. Read how this deal ...

The Berlin-based bridging and swap infrastructure provider has now raised $51.7M in total funding and processed more than $60B in onchain volume.

Fake employees are an emerging cybersecurity threat. Learn how they infiltrate organizations and what steps you can take to ...

Firefly plans to launch its lander toward the moon’s South Pole by the end of 2026. Assuming it arrives in one piece, the ...

Discover how market concentration, AI dominance, and Capital One's transformative acquisition are reshaping portfolios. Read our Q3 2025 commentary for insights!

Running a synchrotron light source is a massive team effort that brings hundreds of highly skilled and specialized professionals together. The radiofrequency (RF) group at the National Synchrotron ...

Base Case shows US$424M post tax NPV5, 33.1% IRR, with a 2.3 year payback at a US$2,300/oz gold price Upside Case shows ...